-
PDF • May 2023Investor / Analyst Meet Transcript 11.05.2023Video • May 2023Recording of Investor / Analyst Call - May 2023PDF • April 2023Communication Of Deduction Of Tax At Source On DividendPDF • April 2023Announcement Under Regulation 30 - NLEM CommunicationVideo • Feb 2023Recording of Investor / Analyst Call - Feb 2023
-
PDF • 2022-07-26Board approves One Time Special Interim DividendPDF • 2022-07-13Interim Dividend and Record DatePDF • 2022-03-08Secretarial Compliance Report for year ended 31st December 2021PDF • 2022-02-23Re-appointment of Statutory AuditorsPDF • 2022-02-23Dividend, AGM Date & Book Closure Date
-
PDF • September 30, 2021Slump Sale and transfer of the Nutraceuticals business of the CompanyPDF • April 01, 2021AGM and E-voting PublicationPDF • March 16, 2021AGM through Video Conferencing FacilityPDF • February 24, 2021Appointment / Re-appointment of Directors, Re-appointment of ChairmanPDF • February 24, 2021Final Dividend, AGM & Book ClosurePDF • February 05, 2021Proposed divestment of Soframycin® and Sofradex® businesses
-
PDF • July 28, 2020Appointment of DirectorsPDF • June 30, 2020Press Release - Sanofi India Launches ‘Allergy Free’PDF • June 12, 2020AGM & E-voting PublicationPDF • May 29, 2020Closing of Transaction - Transfer of Ankleshwar Site to ZentivaPDF • May 28, 2020AGM through Video Conferencing FacilityPDF • May 19, 2020AGM, Book Closure and Dividend Payment DatePDF • March 31, 2020Cessation of the term as Independent Director – Mr. Rangaswamy R. IyerPDF • March 27, 2020Change in Closing date for transaction related to Slump Sale and transfer of Manufacturing Facility at AnkleshwarPDF • March 23, 2020Change in Annual General Meeting (AGM) Date & Book Closure DatePDF • February 25, 2020Final Dividend, AGM & Book ClosurePDF • February 25, 2020Resignation of Non Executive Directors
-
PDF • September 11, 2019Sanofi India Limited to sell Ankleshwar site to ZentivaPDF • July 29, 2019Appointment of Additional Director and Whole Time DirectorPDF • April 11, 2019AGM & E-Voting Publication
-
PDF • October 10, 2018Press Release - Combiflam® Range of Pain Relief Solutions introduces Pain Education Campaign in BiharPDF • September 18, 201826 young people with type 1 diabetes successfully surmount 13,000 ft., in ‘India’s 2nd T1D Challenge 2018’PDF • July 25, 2018Resignation of Non – Executive DirectorPDF • July 25, 2018Interim Dividend 2018 & Record DatePDF • July 25, 2018Appointment of Additional Director and Whole Time DirectorPDF • July 19, 2018Board to Consider Interim Dividend on 25th July 2018PDF • July 02, 2018Authorized officials for disclosure of Material information to Stock ExchangePDF • July 11, 2018Press Release - Combiflam® Range of Pain Relief Solutions launches Pain Education CampaignPDF • April 11, 2018AGM & E-voting PublicationPDF • April 10, 2018Notice of AGM to be held on 08.05.2018PDF • February 22, 2018Final Dividend, AGM & Book ClosurePDF • February 12, 2018Sanofi launches new insulin Toujeo ™ in IndiaPDF • January 15, 2018Resignation of Independent DirectorPDF • January 15, 2018Authorized officials for disclosure of material information to Stock Exchanges
-
PDF • December 15, 2017Sanofi India Limited appoints N. Rajaram as Managing DirectorPDF • December 15, 2017Re-organization of the BoardPDF • September 11, 2017Sanofi Launches ‘Combiflam® ICYHOT™’ Pain Relief Topical in India - 11.09.2017PDF • July 21, 2017Publication of Record datePDF • July 19, 2017Declaration of Dividend and Record DatePDF • April 10, 2017AGM Publication - 08.04.2017PDF • April 06, 2017Clarification on News Article www.reuters.com - 29.03.2017PDF • April 06, 2017Clarification on news article - 03.03.2017PDF • April 06, 2017Notice of AGM to be held on 05.05.2017PDF • February 27, 2017Appointment of Statutory Auditors - 27.02.2017PDF • February 27, 2017Outcome of Boad Meeting - Dividend,AGM,Book closure - 27.02.2017PDF • February 27, 2017Change in Directors - 27.02.2017PDF • January 04, 2017Authorized officials for disclosure of Material information to stock exchange
-
PDF • November 17, 2016Sanofi India collaborates with National Institute of Pharmaceutical Education and Research (NIPER) Kolkata, to promote academic excellence and researchPDF • November 07, 2016SIL -Letter to Stock Exchanges – Change in Company Secretary, Compliance Officer and Key Managerial Personnel - 07.11.2016PDF • July 22, 2016SIL-Letter to Stock Exchanges- Record Date- Interim Dividend for y.e.31.12.2016PDF • June 02, 2016Outcome of Board Meeting - 02.06.2016PDF • June 02, 2016Chairman of the Board of Directors - 02.06.2016PDF • June 02, 2016SIL-Press Release- Chairman of the Board of Directors 02.06.2016PDF • May 23, 2016Company statement on the recall of Combiflam batches - 23.05.2016PDF • May 12, 2016Clarifications on news article Combiflam - 12.05.2016PDF • May 03, 2016Clarification on appointment of Alternate Directors - 03.05.2016PDF • April 29, 2016Draft Articles of Association proposed for adoption at AGM 29.04.2016PDF • March 29, 2016Closure of Register of Members - Final Dividend 2015 - 23.03.2016PDF • March 23, 2016Letter to the Stock Exchanges- Press Release dated 23rd March 2016PDF • March 23, 2016Manufacture and sale of fixed dose combinations - 23.03.2016PDF • March 23, 2016Outcome of Board Meeting held - 23.03.2016
-
PDF • 2015-10-30Clarification on news item appearing in "CNBC TV 18" - 30.10.2015PDF • 2015-10-20Appointment of Alternate Directors - 20.10.2015PDF • 2015-07-23Appointment of Chief Financial Officer - 23.07.2015PDF • 2015-07-23Changes in Board of Directors - 23.07.2015PDF • 2015-07-21Interim Dividend for year ending 31st December 2015 - 21.07.2015PDF • 2015-07-21Sale of building owned by the Company in Andheri, Mumbai 21.07.2015PDF • 2015-06-08Report on order of CCI - 08.06.2015PDF • 2015-03-30Notice of Change of Registered Office - 30.03.2015
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2023
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2022
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2021
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2020
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2019
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2018
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2017
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2016
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2015
You are about to leave sanofiindialtd.com website
By clicking on Proceed, you will be redirected to External Website.
Do you wish to Proceed ?